Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-066702
Filing Date
2025-07-09
Accepted
2025-07-09 16:08:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8586
  Complete submission text file 0001104659-25-066702.txt   10247
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90350 | Film No.: 251113691
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

EIN.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A